Driving change in Cell & Gene Therapies: Key learnings from the SITC Virtual Summit

Chris Learn, Head of Cell and Gene COE at Parexel discusses his participation at the recent Clinical Research Virtual Summit hosted by the Society for Immunotherapy of Cancer, and the implications for clinical research.

Return to Insights Center

Related Insights

Blog

SITC Crisis in Clinical Research Virtual Summit – Collaborating to Drive Change

Aug 24, 2022

Report

New Medicines, Novel Insights: Advancing Precision Oncology

May 14, 2024

Article

Five strategies for meeting the requirements of Project Optimus and improving the chances of approval

Nov 10, 2022

Article

Three ways to improve your chances that insurers will pay for a new CGT

Feb 18, 2021

Blog

We need faster endpoints for targeted cancer drugs, and there is one

Feb 19, 2021

Article

Regulatory, clinical and logistics challenges of ATMPs in clinical research

Apr 22, 2021

Article

Embarking on the Next Era of Precision Medicine

May 11, 2021

Blog

Highlights from ASCO: Our experts weigh in

Jul 13, 2021

Blog

Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial

Nov 19, 2021

Article

New endpoints for early-stage cancer are gaining regulatory traction

Jan 28, 2022

Blog

Chris Learn joins Parexel as Head of the Cell and Gene Center of Excellence

Apr 4, 2022

Blog

Parexel names first Patient Ambassador

Jun 17, 2022